Name

Roscovitine

Alternate Names

CYC202
R-roscovitine
Seliciclib

Abbreviations

None

Category

Chemotherapy

Subcategory

CDK inhibitor- see remarks

NSC Number

None

Primary Site

B-cell lymphomas
Non small cell lung cancer (NSCLC)

Histology

None

Remarks

As of March 2012, roscovitine is currently in clinical trials for NSCLC, AML and B-cell lymphomas. Code in "Other Treatment" until approval received from FDA.

Coding

This drug should be coded
Glossary